Research indicates that turmeric may help mitigate the

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
209
Research indicates that turmeric may help mitigate the growth of MRSA superbugs

http://www.alternativemedicine.news/2018-10-1...rbugs.html

One of the scariest health problems that the world is facing today is the explosion of antibiotic-resistant superbugs like methicillin-resistant staphylococcus aureus, or MRSA. These bacteria can cause infections, pneumonia, and other problems. When left unchecked – which is often the case because it’s notoriously difficult to treat – it can lead to sepsis and death. If antibiotics, one of the most incredible inventions of modern medicine, aren’t enough to address MRSA, what can be done about it? Research shows that nature may have the answer in the form of turmeric.

This yellow-orange root, which is related to the ginger plant, is often used in cooking. Native to India and Southeast Asia, it’s readily available fresh, powdered, and in supplement form. As more information comes to light about its many health benefits, its popularity continues to soar.

Now, a study that was published in the journal Molecule shows the promising role that curcumin, the primary polyphenol found in turmeric that gives it its distinctive golden color, plays in reversing infectious bacteria’s resistance to conventional antibiotics.

Previous research shows that curcumin can have synergistic effects with certain antibiotics. Therefore, the researchers wanted to explore how curcumin would interact with the S. aureus bacteria in various conditions. They found that the growth of the bacteria was inhibited in strains of MRSA that were exposed to curcumin.

A review of the antibacterial action of curcumin against this bacteria published in the Journal of Tropical Medicine found that the Asian spice is indeed effective against S. aureus. In addition, the researchers noted that in vitro experiments showed curcumin’s effects are even more powerful when it’s used in conjunction with other antibacterial agents. They believe that it could one day be developed into a natural antibiotic.

One of the most exciting aspects of this story is the fact that curcumin has little to no toxicity in active doses, unlike many of the other medications that are used to treat infections.

One of the scariest health problems that the world is facing today is the explosion of antibiotic-resistant superbugs like methicillin-resistant staphylococcus aureus, or MRSA. These bacteria can cause infections, pneumonia, and other problems. When left unchecked – which is often the case because it’s notoriously difficult to treat – it can lead to sepsis and death. If antibiotics, one of the most incredible inventions of modern medicine, aren’t enough to address MRSA, what can be done about it? Research shows that nature may have the answer in the form of turmeric.

This yellow-orange root, which is related to the ginger plant, is often used in cooking. Native to India and Southeast Asia, it’s readily available fresh, powdered, and in supplement form. As more information comes to light about its many health benefits, its popularity continues to soar.

Now, a study that was published in the journal Molecule shows the promising role that curcumin, the primary polyphenol found in turmeric that gives it its distinctive golden color, plays in reversing infectious bacteria’s resistance to conventional antibiotics.

Previous research shows that curcumin can have synergistic effects with certain antibiotics. Therefore, the researchers wanted to explore how curcumin would interact with the S. aureus bacteria in various conditions. They found that the growth of the bacteria was inhibited in strains of MRSA that were exposed to curcumin.

A review of the antibacterial action of curcumin against this bacteria published in the Journal of Tropical Medicine found that the Asian spice is indeed effective against S. aureus. In addition, the researchers noted that in vitro experiments showed curcumin’s effects are even more powerful when it’s used in conjunction with other antibacterial agents. They believe that it could one day be developed into a natural antibiotic.

One of the most exciting aspects of this story is the fact that curcumin has little to no toxicity in active doses, unlike many of the other medications that are used to treat infections.

Curcumin’s impressive health achievements
Curcumin has an impressive array of benefits that extend far beyond its ability to fight MRSA. In fact, it has been the subject of thousands of studies and has been found to kill bacteria like E. coli, Helicobacter Pylori, and Bacillus subtilis. It can also inhibit or kill a range of viruses that includes Hepatitis B and C, Coxsackie virus, HIV, HSV-1, Epstein-Barr, and the Japanese encephalitis virus, according to GreenMedInfo.

It’s a natural anti-inflammatory, making it good at combating the low-level inflammation that can spur diseases like metabolic syndrome, degenerative disease, heart disease, Alzheimer’s and cancer. It’s been linked to brain function improvements and a lower risk of brain disease, and it can also be helpful to those with arthritis.

Above all, turmeric has been studied extensively for its anti-cancer effects, and this attention is certainly justified given the prevalence of the disease. However, at the same time, its natural antibiotic action should not be overlooked as we face greater challenges in dealing with the antibiotic-resistant superbugs devastating hospitals throughout the world. As long as doctors continue to prescribed antibiotics for every minor complaint that patients have, it’s a problem that it’s only going to get worse, and finding a solution should be a top priority.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 124

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 90

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Grand Circle Cruise Line Achieves Top Honors for 2025 Travel

Updated Category News Views 271

Grand Circle Cruise Line Recognized Among the Best Grand Circle Cruise Line (GCCL) recently earned the impressive title of #2 Best River Cruise Line in the Travel + Leisure's 2025 World's Best Awards. This accolade showcases the hard work and dedication of the teams and crew members who make each journey remarkable along Europe’s scenic rivers. Celebrating a Special...

Continue Reading
Lancaster Resources Achieves License Approval for Gold Project Exploration

Updated Category News Views 145

Lancaster Resources Secures Approval for Exploration License Vancouver-based Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) is pleased to announce a significant milestone in its gold exploration journey. The company has received confirmation of an Exploration License for the Lake Cargelligo Gold Project from the State of New South Wales. Covering an impressive...

Continue Reading
Future of Vitrectomy Devices: Growth Insights and Trends

Updated Category News Views 93

Understanding the Vitrectomy Devices Market Growth The vitrectomy devices industry has become increasingly vital in treating various eye-related disorders, with significant growth projected in the coming years. By focusing on technological advancements and heightened awareness of eye health, the market is set to expand impressively. According to a recent report, the...

Continue Reading
Exploring RDG Mining's Innovative Cloud Mining Solution

Updated Category News Views 158

Understanding RDG Mining's Latest Offerings In recent times, the popularity of cryptocurrency has surged significantly, with platforms like RDG Mining capitalizing on this trend. RDG Mining is a leading cloud mining service based in the UK that has captured the interest of over 7.5 million users globally, particularly with the rise in various cryptocurrencies, including...

Continue Reading
Pharma Equity Group Updates Its Financial Reporting Strategy

Updated Category News Views 82

Revisions to Financial Reporting and Calendar The board of Pharma Equity Group A/S has recently made the strategic decision to submit only half-yearly financial reports moving forward. This adjustment reflects a shift in focus towards more impactful reporting. As a result, the financial calendar for 2025 has been updated to better align with these new reporting practices....

Continue Reading